WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Kyle Headrick
Associate
Patents and Innovations
Palo Alto
kheadrick@wsgr.com

D858-350-2258

Download vCard
Open PDF

Kyle Headrick is an associate in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where he is a member of the Patents and Innovations practice. His practice focuses on patent prosecution and intellectual property counseling in the fields of chemistry,  pharmaceuticals, and biotechnology.

During law school, Kyle was a legal extern for District Court Judge Cathy Ann Bencivengo, a participant in the Southern District’s Patent Pilot Program. He also gained patent law experience through collaborative legal research projects with his professors at the University of San Diego School of Law.

Experience

Kyle Headrick is an associate in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where he is a member of the Patents and Innovations practice. His practice focuses on patent prosecution and intellectual property counseling in the fields of chemistry,  pharmaceuticals, and biotechnology.

During law school, Kyle was a legal extern for District Court Judge Cathy Ann Bencivengo, a participant in the Southern District’s Patent Pilot Program. He also gained patent law experience through collaborative legal research projects with his professors at the University of San Diego School of Law.

Education
  • J.D., University of San Diego School of Law, 2022Cum Laude
  • B.S., Chemistry, University of Southern California, 2018
Admissions
  • State Bar of California
  • U.S. Patent and Trademark Office
Credentials
Education
  • J.D., University of San Diego School of Law, 2022Cum Laude
  • B.S., Chemistry, University of Southern California, 2018
Admissions
  • State Bar of California
  • U.S. Patent and Trademark Office

Select Publications

"28 U.S.C. § 1498(a), Eminent Domain, and COVID-19," 102 Journal of the Patent and Trademark Office Society 437, 2022

Insights

Select Publications

"28 U.S.C. § 1498(a), Eminent Domain, and COVID-19," 102 Journal of the Patent and Trademark Office Society 437, 2022

Therapeutics and Drug Discovery

  • Antibodies
  • Drug conjugates
  • Peptides
  • Radiopharmaceuticals
  • Small molecule synthesis
  • Small molecules

Chemistry and Material Science

  • Chemical synthesis
  • Chemistry
  • Materials chemistry
  • Organic chemistry
  • Polymorph
  • Process chemistry

Miscellaneous

  • Formulations
Technical Fluency

Therapeutics and Drug Discovery

  • Antibodies
  • Drug conjugates
  • Peptides
  • Radiopharmaceuticals
  • Small molecule synthesis
  • Small molecules

Chemistry and Material Science

  • Chemical synthesis
  • Chemistry
  • Materials chemistry
  • Organic chemistry
  • Polymorph
  • Process chemistry

Miscellaneous

  • Formulations
Focus Areas
  • Patents and Innovations
Recent Insights
Alerts
Continued Scrutiny of Genus Claims: The Written Description and Enablement Requirements for Broad and Previously Undisclosed Subgenera
Executive Summary
Learn More
Client Highlights
Wilson Sonsini Advises FluoRok on Patent Matters Related to £7.7 Million Oversubscribed Funding Round
On September 23, 2024, Oxford-based FluoRok, a deep-tech start-up focused on fluorochemical manufacturing, announced the successful completion of a £7.7 million oversubscribed funding round led by BGF with participation from Green Generation Fund, Volta Energy Technologies, current investors Oxford Science Enterprises and University of Oxford, Excellis Holding, and angels. Wilson Sonsini Goodrich & Rosati advised FluoRok on patent matters related to the transaction.
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.